A rating of 74 puts AstraZeneca plc (AZN) near the top of the Drug Manufacturers - General industry according to InvestorsObserver. AstraZeneca plc's score of 74 means it scores higher than 74% of stocks in the industry. AstraZeneca plc also received an overall rating of 72, putting it above 72% of all stocks. Drug Manufacturers - General is ranked 17 out of the 148 industries.
AZN has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on AZN!
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 72 would rank higher than 72 percent of all stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With AstraZeneca plc Stock Today?
AstraZeneca plc (AZN) stock is higher by 0.18% while the S&P 500 is down -1.09% as of 10:10 AM on Friday, Dec 2. AZN is higher by $0.12 from the previous closing price of $68.34 on volume of 626,032 shares. Over the past year the S&P 500 is lower by -11.90% while AZN is higher by 24.95%. AZN earned $0.82 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 65.02.
Click Here to get the full Stock Report for AstraZeneca plc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
